Australian Healthcare Big Green Snowflakes

SDI

Market Cap: AU$101.0m

Engages in the research and development, manufacture, and marketing of dental restorative materials, whitening systems, and other dental materials in Australia, Europe, the United States, and Brazil.

Australian Clinical Labs

Market Cap: AU$591.4m

Provides pathology diagnostic services in Australia.

Austco Healthcare

Market Cap: AU$103.8m

Operates as provider of healthcare communication solutions in Australia, New Zealand, Asia, Europe, and North America.

Nova Eye Medical

Market Cap: AU$29.8m

Designs, develops, manufactures, markets, and sells surgical devices for the treatment of glaucoma in Australia, the United States, Europe, the Asia Pacific, and internationally.

Sonic Healthcare

Market Cap: AU$12.1b

Offers medical diagnostic and administrative services to medical practitioners, hospitals, community health services, and patients in Australia, the United States, Germany, and internationally.

Ansell

Market Cap: AU$4.2b

Designs, sources, develops, manufactures, distributes, and sells hand and body protection solutions in the Asia Pacific, Europe, the Middle East, Africa, Latin America, the Caribbean, and North America.

Pro Medicus

Market Cap: AU$21.3b

A healthcare informatics company, engages in the development and supply of healthcare imaging software, and radiology information (RIS) system software and services to hospitals, imaging centers, and health care groups in Australia, North America, and Europe.

Cyclopharm

Market Cap: AU$118.4m

Cyclopharm Limited manufacture and sells medical equipment and radiopharmaceuticals in the Asia Pacific, Europe, Canada, and internationally.

ImExHS

Market Cap: AU$16.5m

Offers cloud-based medical imaging solutions in Australia and internationally.

PolyNovo

Market Cap: AU$732.3m

Designs, manufactures, and sells biodegradable medical devices in the United States, Australia, New Zealand, and internationally.

CardieX

Market Cap: AU$24.3m

Engages in the design, manufacture, and marketing of medical devices used in cardiovascular health management in the Americas, Europe, and the Asia Pacific.

Apiam Animal Health

Market Cap: AU$73.9m

A vertically integrated animal health company, provides veterinary products and services to production and companion animals, and equine in Australia.

Lumos Diagnostics Holdings

Market Cap: AU$16.5m

Develops, manufactures, and commercializes point-of-care diagnostic products for diagnosis and management of infectious diseases in the United States and Australia.

Alcidion Group

Market Cap: AU$104.8m

Engages in the development and licensing of healthcare software products in Australia, New Zealand, and the United Kingdom.

Sigma Healthcare

Market Cap: AU$34.5b

Operates as a pharmaceutical wholesaler, distributor, and pharmacy franchisor in Australia and internationally.

Monash IVF Group

Market Cap: AU$296.1m

Provides assisted reproductive and specialist women imaging services in Australia and Malaysia.

Artrya

Market Cap: AU$66.3m

A medical technology company, engages in the development and commercialisation of artificial intelligence platform that detects, diagnoses, and address coronary artery disease in Australia.

Ramsay Health Care

Market Cap: AU$7.5b

Owns and operates hospitals in Australia, and internationally.

EBR Systems

Market Cap: AU$507.1m

Develops implantable systems for wireless tissue stimulation.

BlinkLab

Market Cap: AU$35.8m

Focuses on the development and commercialization of intellectual property related to smartphone-neurobehavioral testing.

Cogstate

Market Cap: AU$227.6m

A neuroscience technology company, engages in the creation, validation, and commercialization of digital brain health assessments used in both academic and industry sponsored research.

CurveBeam AI

Market Cap: AU$40.7m

Engages in the development and manufacture of point-of care specialized weight bearing medical imaging equipment in Europe and North America.

MedAdvisor

Market Cap: AU$52.4m

Provides pharmacy-driven patient engagement solutions in Australia, New Zealand, the United States, and the United Kingdom.

Integral Diagnostics

Market Cap: AU$858.4m

A healthcare services company, engages in the provision of diagnostic imaging services to general practitioners, medical specialists, and allied health professionals and their patients in Australia and New Zealand.

Pacific Smiles Group

Market Cap: AU$290.1m

Owns and operates dental centers under the Pacific Smiles Dental Centres and Nib Dental Care Centres names in Australia.

Freedom Care Group Holdings

Market Cap: AU$4.0m

Provides care and support services to individuals with disabilities in Australia.

Regis Healthcare

Market Cap: AU$2.0b

Engages in the provision of residential aged care services in Australia.

Nanosonics

Market Cap: AU$1.5b

Operates as an infection prevention company globally.

Control Bionics

Market Cap: AU$13.8m

Engages in the research, development, commercialization, and sale of assistive communications technology systems in Australia, North America, and internationally.

Paragon Care

Market Cap: AU$653.8m

Distributes medical equipment, devices, and consumable products in Australia, New Zealand, and Asia.

Micro-X

Market Cap: AU$39.9m

Designs, develops, manufactures, and commercializes healthcare and security markets products using micro-X proprietary cold cathode X-ray technology in Australia, the United States, Asia-Pacific, Europe, the Middle East, and Africa.

Doctor Care Anywhere Group

Market Cap: AU$31.2m

Provides digital healthcare and development services in the United Kingdom, Australia, and the Republic of Ireland.

SomnoMed

Market Cap: AU$95.1m

SomnoMed Limited, together with its subsidiaries, produce and sells devices for the oral treatment of sleep related disorders in the Asia Pacific region, North America, and Europe.

4DMedical

Market Cap: AU$128.4m

Operates as a medical technology company in the United States and Australia.

Oneview Healthcare

Market Cap: AU$205.1m

Develops and sells software services for the healthcare sector in Ireland, the United States, Australia, Ireland, the Middle East, and Asia.

INOVIQ

Market Cap: AU$40.1m

Engages in the developing and commercializing of diagnostic and exosome-based products to enhance the diagnosis and treatment of cancer and other diseases in Australia and the United States.